First clinical experiences with the Mcrpc Therapy in sequence doceaxel-cabazitaxel-enzalutamide for two workshops in the Czech Republic

Date
2017
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Subject(s)
sequential treatmen, metastatic castrationally-resistant prostate cancer, treatment of docetaxel-cabazitaxel-enzalutamide
Citation
Item identifier
https://dspace.tul.cz/handle/15240/31985
ISSN
ISBN
Collections